Effect of Auditory Stimulation by Family Voices in Preventing Delirium: A Randomized Controlled Trial
NCT ID: NCT05732584
Last Updated: 2024-02-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
213 participants
INTERVENTIONAL
2023-03-25
2023-11-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prevention of Delirium in ICU Using Multimodal Interventions
NCT05950958
The Effectiveness of Acupuncture for Delirium in Critically Ill Patients
NCT04312893
Risk Factors of Delirium in Sequential Sedation Patients in Intensive Care Unit
NCT03194360
Incidence and Risk Factors for Delirium in Severely Injured Patients
NCT03023839
Delirium Prevention Guideline for Intensive Care Patients
NCT06403410
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
structured family voice stimulation
Patients in this group were provided with structured family voice stimulation
structured family voice stimulation
The structured family voice stimulation is played to the patients for the first five days after admission to eicu until transfer out or death. The content of the recording is developed according to the structured script.
unstructured family voice stimulation
Patients in this group were provided with unstructured family voice stimulation
unstructured family voice stimulation
The unstructured family voice stimulation is played to the patients for the first five days after admission to eicu until transfer out or death.
Control group
Patients in this group will receive no specific voice stimulation
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
structured family voice stimulation
The structured family voice stimulation is played to the patients for the first five days after admission to eicu until transfer out or death. The content of the recording is developed according to the structured script.
unstructured family voice stimulation
The unstructured family voice stimulation is played to the patients for the first five days after admission to eicu until transfer out or death.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* no other history of emergency, surgery, or ICU admission history within 30 days
* no delirium in the first screening of Emergency Intensive Care Unit(EICU) admission
* with an expected length of stay in EICU longer than 24h and use of sedation medication
Exclusion Criteria
* persistent coma or deep sedation (RASS score of -4 to -5)
* patients without a family member who can cooperate with the recording
* external ear disease or surgery that hinders earphone wearing
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Second Affiliated Hospital, School of Medicine, Zhejiang University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jingfen Jin, Master
Role: PRINCIPAL_INVESTIGATOR
The Second Affiliated Hospital of Medical College of Zhejiang University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Second Affiliated Hospital, School of Medicine, Zhejiang University
Hangzhou, Zhejiang, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2022-1013
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.